BioLife Solutions swings to Q2 FY26 GAAP net income of $45.1 million; revenue rises 21% to $28.5 million vs Q2 FY25
BLFS•Pending acquisition by Repligen
- Repligen agreed to acquire BioLife for about $1.5 billion, with the deal expected to close in Q4 2026.
Q2 FY26 results and profitability
- BioLife Solutions posted Q2 2026 revenue of $28.5 million, up 21% from Q2 2025.
- GAAP operating income was $1.7 million, swinging from a GAAP operating loss a year earlier.
- GAAP net income was $45.1 million, returning to profit; results included a $42.4 million non-cash income tax benefit.
- Non-GAAP adjusted EBITDA rose to $7.4 million, equal to 26% of revenue.
Related News
AIG Q2 FY26 net income per share drops 10% to $1.78; General Insurance net premiums written rise 9% to $7.5 billion
AIG•
Trump unveils trade actions to protect key solar and semiconductor material
TAN•
